New federally financed drug research reveals a stark disparity: children covered by Medicaid are given powerful antipsychotic medicines at a rate four times higher than children whose parents have private insurance. And the Medicaid children are more likely to receive the drugs for less severe conditions than their middle-class counterparts, the data shows.
Those findings, by a team from Rutgers and Columbia, are almost certain to add fuel to a long-running debate. Do too many children from poor families receive powerful psychiatric drugs not because they actually need them — but because it is deemed the most efficient and cost-effective way to control problems that may be handled much differently for middle-class children?
The questions go beyond the psychological impact on Medicaid children, serious as that may be. Antipsychotic drugs can also have severe physical side effects, causing drastic weight gain and metabolic changes resulting in lifelong physical problems.
On Tuesday, a pediatric advisory committee to the Food and Drug Administration met to discuss the health risks for all children who take antipsychotics. The panel will consider recommending new label warnings for the drugs, which are now used by an estimated 300,000 people under age 18 in this country, counting both Medicaid patients and those with private insurance.
Meanwhile, a group of Medicaid medical directors from 16 states, under a project they call Too Many, Too Much, Too Young, has been experimenting with ways to reduce prescriptions of antipsychotic drugs among Medicaid children.
They plan to publish a report early next year.
The Rutgers-Columbia study will also be published early next year, in the peer-reviewed journal Health Affairs. But the findings have already been posted on the Web, setting off discussion among experts who treat and study troubled young people.
Some experts say they are stunned by the disparity in prescribing patterns. But others say it reinforces previous indications, and their own experience, that children with diagnoses of mental or emotional problems in low-income families are more likely to be given drugs than receive family counseling or psychotherapy.
Part of the reason is insurance reimbursements, as Medicaid often pays much less for counseling and therapy than private insurers do. Part of it may have to do with the challenges that families in poverty may have in consistently attending counseling or therapy sessions, even when such help is available. 安全工程师考试 安全工程师考试试题 安全工程师考试报名 安全工程师考试时间 安全工程师考试内容 安全工程师考试试题 安全工程师考试成绩查询法律知识:法律知识热点 安全工程师法律知识热点 法律知识热点辅导 法律知识热点问题法律知识试题 安全工程师法律知识试题 法律知识试题及答案 法律知识试题下载 历年安全工程师法律知识试题 法律知识模拟试题 法律知识模拟试卷管理知识： 管理知识测试安全工程师管理知识 安全工程师管理知识试题安全工程师试题 安全工程师题及答案 安全工程师试题下载安全工程师模拟题 安全工程师模拟试卷生产技术：安全工程师生产技术指导 安全工程师生产技术技巧生产技术试题 安全工程师生产技术试题 安全工程师生产技术真题及答案生产技术模拟试题 安全工程师生产技术模拟题案例： 安全工程师案例 案例成绩查询案例试题 安全工程师案例试题 安全工程师案例试题及答案 安全工程师案例经验技巧安全工程师案例模拟试题
“It’s easier for patients, and it’s easier for docs,” said Dr. Derek H. Suite, a psychiatrist in the Bronx whose pediatric cases include children and adolescents covered by Medicaid and who sometimes prescribes antipsychotics. “But the question is, ‘What are you prescribing it for?’ That’s where it gets a little fuzzy.”
Too often, Dr. Suite said, he sees young Medicaid patients to whom other doctors have given antipsychotics that the patients do not seem to need. Recently, for example, he met with a 15-year-old girl. She had stopped taking the antipsychotic medication that had been prescribed for her after a single examination, paid for by Medicaid, at a clinic where she received a diagnosis of bipolar disorder.
Why did she stop? Dr. Suite asked. “I can control my moods,” the girl said softly.
After evaluating her, Dr. Suite decided she was right. The girl had arguments with her mother and stepfather and some insomnia. But she was a good student and certainly not bipolar, in Dr. Suite’s opinion.
“Normal teenager,” Dr. Suite said, nodding. “No scripts for you.”
Because there can be long waits to see the psychiatrists accepting Medicaid, it is often a pediatrician or family doctor who prescribes an antipsychotic to a Medicaid patient — whether because the parent wants it or the doctor believes there are few other options.
Some experts even say Medicaid may provide better care for children than many covered by private insurance because the drugs — which can cost $400 a month — are provided free to patients, and families do not have to worry about the co-payments and other insurance restrictions.
“Maybe Medicaid kids are getting better treatment,” said Dr. Gabrielle Carlson, a child psychiatrist and professor at the Stony Brook School of Medicine. “If it helps keep them in school, maybe it’s not so bad.”
In any case, as Congress works on health care legislation that could expand the nation’s Medicaid rolls by 15 million people — a 43 percent increase — the scope of the antipsychotics problem, and the expense, could grow in coming years.
Even though the drugs are typically cheaper than long-term therapy, they are the single biggest drug expenditure for Medicaid, costing the program $7.9 billion in 2006, the most recent year for which the data is available.
The Rutgers-Columbia research, based on millions of Medicaid and private insurance claims, is the most extensive analysis of its type yet on children’s antipsychotic drug use. It examined records for children in seven big states — including New York, Texas and California — selected to be representative of the nation’s Medicaid population, for the years 2001 and 2004.
偏头疼 偏头疼怎么办 偏头疼的原因 偏头疼的症状 偏头疼是怎么回事 偏头疼怎么治疗 治疗偏头疼的偏方 偏头疼吃什么药 孕妇偏头疼 神经性偏头疼症状 如何治偏头疼 偏头疼吃什么 什么是偏头疼 头痛的治疗药物 产妇头痛应该怎么办 宝宝偏头痛原因 孩子头痛怎么护理 孕妇偏头疼护理 重症肌无力 重症肌无力的治疗 重症肌无力的症状 重症肌无力的护理 眼肌型重症肌无力 重症肌无力的病因 重症肌无力饮食 小儿重症肌无力 抑郁症 抑郁症的治疗 抑郁症的饮食 抑郁症的保健 抑郁症的表现 产后抑郁症 抑郁症的症状 什么是抑郁症 抑郁症怎么治疗 轻度抑郁症的表现 重度抑郁症的表现 产前抑郁症的表现 躁狂抑郁症的表现 老年抑郁症的表现 产后抑郁症的治疗 产后抑郁症的病因 什么是产后抑郁症 抑郁症的心理治疗 治疗抑郁症的药物 抑郁症的中医治疗 抑郁症吃什么药 抑郁症吃什么食物 抑郁症的测试 焦虑症 焦虑症的症状 焦虑症的治疗 焦虑症的诊断 焦虑症的保健 焦虑症的表现 治疗焦虑症 什么是焦虑症 焦虑症的心理治疗 焦虑症的原因 焦虑症怎么治疗 治疗焦虑症的偏方 中医治疗焦虑症 考试焦虑症的原因 中学生考试焦虑症 焦虑症吃什么药 焦虑症的饮食 脑出血脑溢血 脑出血的治疗 重症脑出血的治疗 脑出血的保健 脑出血的症状 脑出血后遗症 脑出血的原因 脑出血病人的护理 脑溢血的症状 脑溢血前兆 脑血栓与脑出血区别 脑出血的护理 高血压引起的脑出血 脑出血前兆 新生儿脑出血 脑溢血能治好吗 脑溢血后遗症 脑溢血的治疗 脑溢血会遗传吗 预防脑溢血 婴儿脑出血症状 轻微脑出血症状 脑出血的护理措施 脑出血发生原因 新生儿脑出血的原因 脑出血病人的饮食 脑溢血手术 什么是脑溢血 脑出血药物治疗 脑出血严重吗 脑出血怎么办 脑出血后期治疗 脑出血的并发症 癫痫 癫痫的症状 癫痫的治疗 癫痫的保健 癫痫急救 癫痫的病因 小儿癫痫 癫痫病能治愈吗 治疗癫痫病最好的药 小儿癫痫的症状 小儿癫痫能治好吗 小儿癫痫病的治疗 小儿癫痫的种类 小儿癫痫的原因 新生儿癫痫病症状 癫痫的症状表现 中医治疗癫痫病 癫痫病怎么治疗 如何治疗癫痫病 癫痫遗传吗 癫痫要怎样诊断检查 小儿的癫痫护理措施 癫痫的护理方 治癫痫的药物 癫痫患者饮食的原则 癫痫患者发作怎么办 治癫痫病偏方 癫痫症的前期
The data indicated that more than 4 percent of patients ages 6 to 17 in Medicaid fee-for-service programs received antipsychotic drugs, compared with less than 1 percent of privately insured children and adolescents. More recent data through 2007 indicates that the disparity has remained, said Stephen Crystal, a Rutgers professor who led the study. Experts generally agree that some characteristics of the Medicaid population may contribute to psychological problems or psychiatric disorders. They include the stresses of poverty, single-parent homes, poorer schools, lack of access to preventive care and the fact that the Medicaid rolls include many adults who are themselves mentally ill.
As a result, studies have found that children in low-income families may have a higher rate of mental health problems — perhaps two to one — compared with children in better-off families. But that still does not explain the four-to-one disparity in prescribing antipsychotics.
Professor Crystal, who is the director of the Center for Pharmacotherapy at Rutgers, says his team’s data also indicates that poorer children are more likely to receive antipsychotics for less serious conditions than would typically prompt a prescription for a middle-class child.
But Professor Crystal said he did not have clear evidence to form an opinion on whether or not children on Medicaid were being overtreated.
“Medicaid kids are subject to a lot of stresses that lead to behavior issues which can be hard to distinguish from more serious psychiatric conditions,” he said. “It’s very hard to pin down.”
And yet Dr. Mark Olfson, a psychiatry professor at Columbia and a co-author of the study, said at least one thing was clear: “A lot of these kids are not getting other mental health services.”
The F.D.A. has approved antipsychotic drugs for children specifically to treat schizophrenia, autism and bipolar disorder. But they are more frequently prescribed to children for other, less extreme conditions, including attention deficit hyperactivity disorder, aggression, persistent defiance or other so-called conduct disorders — especially when the children are covered by Medicaid, the new study shows.
Although doctors may legally prescribe the drugs for these “off label” uses, there have been no long-term studies of their effects when used for such conditions.
The Rutgers-Columbia study found that Medicaid children were more likely than those with private insurance to be given the drugs for off-label uses like A.D.H.D. and conduct disorders. The privately insured children, in turn, were more likely than their Medicaid counterparts to receive the drugs for F.D.A.-approved uses like bipolar disorder.
Even if parents enrolled in Medicaid may be reluctant to put their children on drugs, some come to rely on them as the only thing that helps.